Page last updated: 2024-10-29

isradipine and Hemorrhage

isradipine has been researched along with Hemorrhage in 1 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Hemorrhage: Bleeding or escape of blood from a vessel.

Research Excerpts

ExcerptRelevanceReference
" We identified 43 subjects from general practice with uncomplicated mild to moderate hypertension to compare the effects of the calcium antagonist isradipine with that of the beta-blocker atenolol on platelet function, plasma beta-thromboglobulin levels, fibrinolysis, and serum lipids in a randomised double-blind parallel group study."5.08Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects. ( Carney, S; Gillies, A; Mason, A; McPherson, J; Smith, A; Taylor, M, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, A1
McPherson, J1
Taylor, M1
Mason, A1
Carney, S1
Gillies, A1

Trials

1 trial available for isradipine and Hemorrhage

ArticleYear
Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects.
    Journal of human hypertension, 1997, Volume: 11, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Atenolol; beta-Thromboglobulin; Blood Platelets; Blood Pressure;

1997